Clarins
This article was originally published in The Rose Sheet
Executive Summary
Net profit rose 11.2% at constant exchange rates to $116.4 mil. (€1=$1.20) in 2005, due in part to "a sharp decrease in net interest expense as a result of...debt reduction," in addition to a reduction in average current tax rate and unrealized gains from its stake in L'Occitane, French beauty firm reports March 24. Net profit was up 11.4% on a like-for-like basis. Operating profit rose 4.5% to $152.1 mil. Clarins' Beauty operating profit advanced 9.4%, or 9% like-for-like, to $112.5 mil. during the year, while Perfumes division operating profit declined 7.3%, or 6.4% on a like-for-like basis, to $39.6 mil. Clarins reported 2005 net sales in February (1"The Rose Sheet" Feb. 6, 2006, p. 6)...
You may also be interested in...
Clarins Will Step Up Skin Care Offerings To Grow Segment In ’06
Clarins is targeting its skin care business as a primary area of growth this year, the French beauty firm announced in a Feb. 3 sales release
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.